ZEUS System (Zio Watch) vs ASSURE Wearable ECG

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Kestra Medical Technologies

AI Verdict

Both the ZEUS System (Zio Watch) and ASSURE Wearable ECG are FDA-cleared, AI-powered wearable devices for continuous cardiac monitoring, making them direct competitors in the remote patient monitoring space. The ZEUS System emphasizes advanced AI for detecting and characterizing Atrial Fibrillation and other arrhythmias with clinically actionable reports. In contrast, the ASSURE Wearable ECG highlights its comfortable SensorFit Garment, robust artifact filtering, and alert-based notifications for continuous heart rate monitoring and data collection.

Choose ZEUS System (Zio Watch) if…

Choose the ZEUS System (Zio Watch) if your primary need is long-term, AI-powered diagnostic monitoring specifically for detecting and characterizing Atrial Fibrillation (AFib) and other complex cardiac arrhythmias. This tool is ideal for physicians seeking highly accurate, actionable insights and comprehensive reports over an extended period to guide treatment decisions.

View ZEUS System (Zio Watch) →

Choose ASSURE Wearable ECG if…

Choose the ASSURE Wearable ECG if you require comfortable, continuous heart rate monitoring and data collection for at-risk cardiac patients, with a focus on reliable data acquisition and immediate alert notifications. Its non-adhesive SensorFit Garment and advanced artifact filtering make it suitable for patients needing discreet, long-term trend monitoring with minimal disruption.

View ASSURE Wearable ECG →

For physicians evaluating AI-powered cardiac monitoring, the ZEUS System (Zio Watch) and ASSURE Wearable ECG offer distinct strengths. The ZEUS System, from iRhythm Technologies, is best suited for comprehensive, long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias. It provides detailed, clinically actionable reports for up to 14 days of continuous monitoring, with a high physician agreement rate on its end-of-wear reports. This makes it ideal for diagnostic purposes where a thorough understanding of arrhythmia burden and characteristics is paramount.

In contrast, Kestra Medical Technologies’ ASSURE Wearable ECG focuses on continuous heart rate monitoring, robust artifact filtering through its Adaptive Patient Intelligence™, and alert-based notifications for at-risk cardiac patients. The key practical difference lies in their primary function: ZEUS excels at detailed arrhythmia diagnosis and characterization over an extended period, while ASSURE prioritizes continuous heart rate surveillance with real-time alerts and advanced motion artifact reduction.

Therefore, a physician primarily seeking a comprehensive diagnostic tool for identifying and quantifying AFib and other arrhythmias over an extended duration should consider the ZEUS System. Conversely, for patients requiring continuous heart rate monitoring with a focus on immediate alerts and effective artifact management, the ASSURE Wearable ECG would be the more appropriate choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ZEUS System (Zio Watch) ASSURE Wearable ECG
Pricing Contact vendor Contact for pricing.
Deployment Cloud-based system with a wearable device Wearable device, mobile application, and cloud-based remote patient data platform.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool B emphasizes patient comfort through its SensorFit Garment, featuring non-adhesive, cushioned, and machine-washable ECG sensors available in multiple styles and sizes, suggesting superior physical usability and convenience. While Tool A highlights its device as small, comfortable, and suitable for daily activities including showering, Tool B's detailed garment design and home setup instructions indicate a strong focus on patient-centric physical wearability.

Clinical Value

ZEUS System (Zio Watch)

Tool A demonstrates stronger clinical value with its FDA-cleared, AI-powered algorithm specifically designed for advanced detection and characterization of Atrial Fibrillation (AFib) and other arrhythmias, boasting 99% physician agreement with its reports. It also provides interval-level sensitivity and specificity metrics for its AFib detection algorithm, and characterizes AFib burden, offering deeper diagnostic insights. In contrast, Tool B's Wearable ECG is a non-therapeutic device whose reports do not contain diagnostic interpretation, focusing on heart rate monitoring and event storage for clinician review, indicating a less direct diagnostic role.

Pricing & Value

ZEUS System (Zio Watch)

While both tools require contacting the vendor for pricing, Tool A offers greater transparency and support regarding patient costs. It explicitly states coverage by Medicare and major commercial insurance plans, and provides detailed patient financial assistance programs including discounted self-pay, installment plans, and financial hardship assistance. Tool B lacks comparable public information on patient financial support or billing models, making its overall value proposition less clear from a patient affordability perspective.

Enterprise Readiness

ZEUS System (Zio Watch)

Both tools are HIPAA compliant, offer BAAs, and utilize cloud-based platforms with provider portals. However, Tool A stands out with its explicit and deep integration with Epic via the Aura network, being the first medical device company to achieve this, which significantly streamlines workflows and reduces integration time for a large segment of healthcare systems. Tool B mentions support for various data standards and deployment models, but does not detail specific, high-profile EHR integration partnerships or the associated workflow efficiencies.

Innovation

ZEUS System (Zio Watch)

Tool A demonstrates advanced innovation through its AI-powered ZEUS System, which leverages a vast repository of labeled ECG data for deep-learned algorithm development, enabling continuous ECG and PPG data collection for AFib detection and burden characterization. Tool B's innovation focuses on its SensorFit Garment for comfort and signal quality, and Adaptive Patient Intelligence for motion artifact filtering. While valuable, Tool A's multi-modal data collection and advanced AI for specific arrhythmia burden characterization represent a more significant leap in diagnostic capability.

Support & Docs

ZEUS System (Zio Watch)

Tool A offers a more comprehensive and transparent support system, including dedicated patient advocates for financial and insurance questions, direct customer service via phone and email, and go-live support for EHR integration. While Tool B provides provider resources like Instructions for Use and 'ASSURE Assist service' for post-event support, Tool A's multi-faceted approach, particularly its financial advocacy and integration support, appears more robust and accessible for both patients and clinicians.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ZEUS System (Zio Watch) ASSURE Wearable ECG
Name ZEUS System (Zio Watch) ASSURE Wearable ECG
Company iRhythm Technologies Kestra Medical Technologies
Description FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.
Key Features Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection; AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis; Long-term continuous monitoring for up to 14 days; Detects and characterizes Atrial Fibrillation (AFib) burden; Cloud-based data analytics and processing; Clinically actionable reports with high physician agreement (99%); ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management; MyZiou00ae patient app for digital symptom logging, educational content, and reminders Wearable ECG device for continuous heart rate monitoring; SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts; Automatic episode storage; Alert-based notifications; Physiologic trend data; Kestra CareStation remote patient data platform for clinician review
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The ZEUS System (Zio Watch) is specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. The ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into a digital healthcare platform for at-risk cardiac patients.
The ZEUS System (Zio Watch) offers long-term continuous monitoring for up to 14 days. The ASSURE Wearable ECG provides continuous heart rate monitoring, but a specific maximum duration is not detailed in the provided information.
The ZEUS System (Zio Watch) collects continuous ECG and PPG data via its wearable biosensor. The ASSURE Wearable ECG collects continuous ECG data through its SensorFit Garment.
The ZEUS System (Zio Watch) includes a MyZio patient app for digital symptom logging, educational content, and reminders. The ASSURE Wearable ECG integrates a mobile application and a wearable device for data collection, but specific patient-facing engagement features like symptom logging are not detailed.
The ZEUS System (Zio Watch) provides clinically actionable reports with high physician agreement (99%) and characterizes Atrial Fibrillation (AFib) burden, accessible via the ZioSuite portal and provider mobile app. The ASSURE Wearable ECG offers automatic episode storage, alert-based notifications, and physiologic trend data for clinician review on the Kestra CareStation remote patient data platform.
The ZEUS System (Zio Watch) utilizes a wearable biosensor in the form of a Zio Watch for data collection. The ASSURE Wearable ECG features a SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors for continuous monitoring.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.